share_log

Brookline Capital Downgrades Dare Bioscience to Hold

Moomoo 24/7 ·  Apr 17 13:28

Brookline Capital analyst Kemp Dolliver downgrades Dare Bioscience (NASDAQ:DARE) from Buy to Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment